Nano-X Imaging (NNOX) Fundamentals 2026 — Revenue Analysis | SniperIQ
Nano-X Imaging (NNOX) is a IL-listed Healthcare company in Medical - Devices with a market capitalization of $71M, trading at
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Nano-X Imaging's market cap?
Nano-X Imaging (NNOX) has a market capitalization of approximately $71M, trading at
What is Nano-X Imaging's P/E ratio?
Nano-X Imaging's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 0.6x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Nano-X Imaging?
Nano-X Imaging runs a net profit margin of -523.8%, a gross margin of -85.7%, and an operating margin of -422.9%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Nano-X Imaging generate?
Nano-X Imaging reported revenue of
Does Nano-X Imaging pay a dividend?
Nano-X Imaging does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is Nano-X Imaging financially healthy?
Nano-X Imaging carries a debt-to-equity ratio of 0.06x and a current ratio of 3.64x, with a market beta of 1.23. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Nano-X Imaging a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Nano-X Imaging (NNOX) the key facts are: market cap $71M, revenue
Track Nano-X Imaging's full fundamentals live
Get Nano-X Imaging's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.